期刊文献+

DMT1在APP/PS1转基因小鼠大脑皮层老年斑内的定位研究 被引量:3

Localization of DMT1 in Cerebral Cortex of APP/PS1 Transgenic Mouse Brain
下载PDF
导出
摘要 目的研究二价金属离子转运体1(divalent metal transporter 1,DMT1)在APP/PS1转基因小鼠大脑皮层内的定位分布,探讨DMT1异常表达影响脑铁代谢平衡从而参与AD发病的可能机制。方法应用免疫组织化学方法观察DMT1在9月龄APPsw/PS1小鼠大脑皮层的阳性分布;应用免疫荧光双标技术和共聚焦激光扫描显微镜观察DMT1蛋白和β淀粉样蛋白(β-amyloid peptide,Aβ)在APP/PS1转基因小鼠大脑皮层老年斑内的一致性分布和位置关系。结果APP/PS1转基因小鼠大脑皮层老年斑内均有DMT1阳性表达;DMT1和Aβ免疫双标发现DMT1免疫阳性产物与Aβ共存于老年斑,二者分布具有一致性。结论DMT1在APP/PS1转基因小鼠大脑皮层老年斑内大量表达,其分布与Aβ具有一致性,提示DMT1可能参与AD脑内Aβ沉积和老年斑形成。 Objective To investigate the distribution and localization of divalent metal transporter 1(DMT1) in the cerebral cortex of APP/PS1 transgenic mouse, and to explore the possible role of DMT1 in Alzheimer disease (AD) pathogenesis. Method Immunohistochemistry, immunofluorescence and confoeal laser scanning microscopy were used to analyze the distributions of DMT1 and β -amyloid protein (A β) and the relationship between these two proteins in cerebral cortex of APP/PS1 mouse. Results DMT1 immunoreactive product was seento be localized in the senile plaques withinthe cerebral cortex of APP/PS1 transgenic mouse. Almost all of senile plaques presented DMT1 immunoreactivity with different expression. Confocal microscopic results revealed that a co-localization of DMT1 and A β was found in the senile plaques. Conclusion The abundant expression of DMT1 in A β senile plaques suggests that DMT1 may be involved in the deposition of A β and the formation senile plaque in AD brain.
出处 《解剖科学进展》 CAS 2008年第4期349-352,共4页 Progress of Anatomical Sciences
基金 教育部新世纪优秀人才支持计划(NCET-04-0288)
关键词 APP/PS1转基因小鼠 二价阳离子转运体 NRAMP2 Β淀粉样蛋白 老年斑 APP/PS1 transgenic mouse divalent cation transporter 1 NRAMP2 β-amyloid protein senile plaque
  • 相关文献

参考文献5

二级参考文献47

  • 1张丽红,池志宏,高慧玲,王占友.锌离子参与阿尔茨海默病Aβ老年斑形成的形态学证据[J].中国组织化学与细胞化学杂志,2006,15(1):87-90. 被引量:13
  • 2田之莹,高慧玲,池志宏,张丽红,王占友.游离锌离子在小鼠颈上神经节的分布[J].解剖科学进展,2006,12(1):3-5. 被引量:7
  • 3王辛,李花,郑玮,高慧玲,荣明,王占友.游离锌离子在小鼠视网膜的定位研究[J].解剖科学进展,2006,12(4):297-299. 被引量:7
  • 4Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, Nussberger S, Gollan JL, Hediger MA. Cloning and characterization of a mammalian protoncoupled metal-ion transporter. Nature 1997, 388 (6641) :482 - 488.
  • 5Schmidt N, Ferger B. Neurochemical findings in the MPTP model of Parkinson' s disease. J Neural Transm 2001 , 108 : 1263 - 1282.
  • 6Russ H, Staust K, Martel F, Gliese M, Schomig E. The extraneuronal transporter for monoamine transmitters existsin cells derived from human central nervous system gila.Eur J Neurosci 1996,8:1256 - 1264.
  • 7Blum D, Torch S, Lambeng N, Nissou MF, Benabid AL,Sadoul R, Vema JM. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP:contribution to the apoptotic theory in Parkinson' s disease. Ping Neurobiol 2001 ,65 : 135 - 172.
  • 8Mochizuki H, lmal H, Endo K, Yokomizo K, Murata Y,Hattorl N, Mizuno Y. Iron accumulation in the substantia nigra of 1-methy-4-phenyl-1, 2, 3, 6-tetrahydropyridine( MPTP)-induced hemiparkinsonian monkeys. Neurosci Iett 1994,68:251 -253.
  • 9Yantiri FI Andersen JK. The role of iron in Parkinson'sdisease and 1-methy-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. IUBMB Life 1999,8:139-141.
  • 10He Y, Lee T, Leong SK.Time-course and localization of transgerring receptor expression in the substantia nigra of 6-hydroxydopamine-induced Parkinsonian rats. Neuroscience 1999 ,91 (2) :579 -585.

共引文献46

同被引文献14

  • 1Wei Zheng , 1, Na Xin , 1, Zhi-Hong Chi , Jie Zhang , Bo-Lu Zhao , Jia-Yi Li , Zhan-You Wang , 2 Key Laboratory of Cell Biology, Ministry of Public Health of China, Laboratory of Cell Engineering, China Medical University, Shenyang, PR China State Key laboratory of Brain and Cognitive Sciences, Institute of Biophysics, Academia Sinica, Beijing, PR China,Department of Experimental Medical Science, Lund University, Sweden.Upregulation of Divalent Metal Transporter 1 (DMT1) Is Involved in Amyloid Precursor Protein Processing and Aβ Generation[J].生物物理学报,2009,25(S1):110-110. 被引量:8
  • 2曹立梅,毕桂南.5-脂氧合酶与脑缺血再灌注[J].国外医学(脑血管疾病分册),2004,12(11):850-853. 被引量:2
  • 3Liu G Huang W Moir RD Vanderburg CR Lai B Peng Z Tanzi RE Rogers JT Huang X.Metal exposure and Alzheimer's pathogenesis.[J].中国生物学文摘,2006,20(9):9-10. 被引量:8
  • 4Chu J, Pratic b D. 5-1ilxxygena. as ar endogenous rnodulalor of anyloid [3 formation in vivo [J]. Ann Neurol, 201 |, 69 (l): 34-46.
  • 5Chinnici CM, Yao Y, Pratic 1). The 5-1ipoxygenase enzymatic pathway in the mouse brain: young versus old[J]. Neurobiol Aging, 2007, 28: 1457-1462.
  • 6Taisuke T. Seeretase inhibitors and modulato for Alzheimer's disease treatment/J]. Expert Rev Neurother, 2009, 9(5): 661-679.
  • 7Amniai L, Barbier P, Sillen A, et al. Alzheimer disease specific phosphoepitopes of Tau interfere with assembly of tubulin but nol binding to microtubules[J]. The FASEB Journal, 2009, 23(4): 1146- 1152.
  • 8Avila J. Tau kinases and phosphatases[J]. J Cel Mol Med, 2008, 12(1): 258-259.
  • 9Qu T, Manev R, Manev H. 5-Lipoxygenase (5-LOX) protrter palyrrgtp}tism in patients with early-onset and late-onset Alzheimer's disease[J]. J Neuropsyehiatry Clin Neurosci, 2001, 13: 304-305.
  • 10Chu J, Phillip F, Golde TE, et al. Adeno-associated virus-mediated brain delivery of 5-lipoxygenase modulates the AD-like phenotype of APP mice[J]. Mol Neurodegenerat, 2012, 7 (1): 1.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部